A 24-Week International, Multi-center, Randomized, Parallel-group, Double-blind Trial to Evaluate Metformin Extended Release Monotherapy Compared to Metformin Immediate Release Monotherapy in Adults Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
A 24-Week International, Multi-center, Randomized, Parallel-group, Double-blind Trial to Evaluate Metformin Extended Release Monotherapy Compared to Metformin Immediate Release Monotherapy in Adults Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
The purpose of this study is determine if Metformin XR monotherapy in subjects with type 2 diabetes is non-inferior to Metformin IR monotherapy
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
Exclusion Criteria:
Phoenix, Arkansas 85020, United States
Colorado Springs, Colorado 80920, United States
Evansville, Indiana 47725, United States
Myen, 56727, Germany
Hodmezvasarhely, Csongrád megye 6800, Hungary
Szobathely, H-9700, Hungary
Tg Mures, 540142, Romania
Phoenix, Durban, KwaZulu-Natal 4068, South Africa
Fife, FIF KY14 7AW, United Kingdom
Cardenden Fife, KY5 0JE, United Kingdom